Cargando…
E2F1 as a potential prognostic and therapeutic biomarker by affecting tumor development and immune microenvironment in hepatocellular carcinoma
BACKGROUND: E2F1 plays a crucial role in cell cycle regulation. However, the exact role of E2F1 in liver hepatocellular carcinoma (LIHC) remains controversial. This study aimed to integrate disparate data by bioinformatics for a deeper insight into the possible roles of E2F1 in LIHC. METHODS: Differ...
Autores principales: | Tan, Zhibo, Chen, Min, Peng, Feng, Yang, Pengfei, Peng, Zhaoming, Zhang, Zhe, Li, Xin, Zhu, Xiaopeng, Zhang, Lei, Zhao, Yujie, Liu, Yajie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459514/ https://www.ncbi.nlm.nih.gov/pubmed/36093522 http://dx.doi.org/10.21037/tcr-22-218 |
Ejemplares similares
-
Identification of Therapeutic Targets and Prognostic Biomarkers among Genes from the Mediator Complex Family in the Hepatocellular Carcinoma Tumour-Immune Microenvironment
por: Tan, Wei, et al.
Publicado: (2022) -
ZWINT is a Promising Therapeutic Biomarker Associated with the Immune Microenvironment of Hepatocellular Carcinoma
por: Lin, Tong, et al.
Publicado: (2021) -
Evaluation of Hybrid VMAT Advantages and Robustness Considering Setup Errors Using Surface Guided Dose Accumulation for Internal Lymph Mammary Nodes Irradiation of Postmastectomy Radiotherapy
por: Zhang, Zhe, et al.
Publicado: (2022) -
CXC Chemokines as Therapeutic Targets and Prognostic Biomarkers in Skin Cutaneous Melanoma Microenvironment
por: Zhou, Xuezhi, et al.
Publicado: (2021) -
Advantages and robustness of partial VMAT with prone position for neoadjuvant rectal cancer evaluated by CBCT-based offline adaptive radiotherapy
por: Zhang, Zhe, et al.
Publicado: (2023)